Quest Diagnostics CEO Stephen Rusckowski's 2018 pay slips 4% to $10M

Quest Diagnostics reports 2018 executive compensation

By ExecPay News

Published: April 3, 2019

Quest Diagnostics reported fiscal year 2018 executive compensation information on April 3, 2019.
In 2018, five executives at Quest Diagnostics received on average a compensation package of $4.3M, a 3% decrease compared to previous year.
Average pay of disclosed executives at Quest Diagnostics
Stephen H. Rusckowski, Chief Executive Officer, received $10M in total, which decreased by 4% compared to 2017. 47% of Rusckowski's compensation, or $4.7M, was in stock awards. Rusckowski also received $789K in non-equity incentive plan, $3.1M in option awards, $1.1M in salary, as well as $315K in other compensation.
Mark J. Guinan, Chief Financial Officer, received a compensation package of $3.2M, which decreased by 7% compared to previous year. 43% of the compensation package, or $1.4M, was in stock awards.
James E. Davis, Executive Vice President, General Diagnostics, earned $3.1M in 2018, a 6% decrease compared to previous year.
Carrie Eglinton Manner, Senior Vice President, Advanced Diagnostics, received $2.9M in 2018, which increases by 10% compared to 2017.
Catherine T. Doherty, Senior Vice President, Group Executive Clinical Franchises, earned $2.3M in 2018, a 8% decrease compared to previous year.

Related executives

Stephen Rusckowski

Quest Diagnostics

Chief Executive Officer

Mark Guinan

Quest Diagnostics

Chief Financial Officer

James Davis

Quest Diagnostics

Chief Executive Officer

Carrie Manner

Quest Diagnostics

Senior Vice President, Advanced and General Diagnostics and Clinical Solutions

Catherine Doherty

Quest Diagnostics

Senior Vice President, Regional Businesses

You may also like

Source: SEC filing on April 3, 2019.